Control CRISPR/Cas9 Plasmid is a plasmid… and 2 more items

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has awarded a purchase order (PO) to Santa Cruz Biotechnology of Dallas, Texas, for specialized scientific research plasmids. The contract, numbered 4800152848, covers the procurement of three distinct plasmid types: two Control CRISPR/Cas9 Plasmids, one CRISPR/Cas9 Knockout (KO) Plasmid, and one connexin 43 Homology-Directed Repair (HDR) Plasmid. The total contract value is $995.00, with line items priced at $84.00 for the control plasmids, $390.00 for the KO plasmid, and $437.00 for the HDR plasmid.

The purchase order, issued on October 23, 2025, with a delivery date of October 30, 2025, specifies delivery to the Durham Research Center (DRC2), Room 1048. The contract is structured with Net 30 payment terms and is tax-exempt under number 05-8905401. The plasmids are intended for scientific research purposes, with the specific research objectives not detailed in the provided documentation. The order is governed by the University of Nebraska's Standard Terms of Purchase, indicating a standard procurement process for specialized research materials.